Apollo Neuroscience
Pittsburgh, US · Founded 2017 · Delaware corporation · 1 known investors
Improves the body's resilience to stress to help users focus, sleep, and stay energized.
Founders & leadership
Apollo Neuroscience was founded in 2017 by Kathryn Fantauzzi.
KF
Kathryn FantauzziFounder
Investors · 1
Reported raises · per SEC filings
Form D private placements$23.8M disclosed across 5 rounds · 2018–2024
▶$500KraisedApr 2024 · 1 investors · Other Health CareRule 506(b)
▶$500KraisedApr 2024 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gary JohnsonDirector
- Alan CannistraroExecutive Officer, Director
- Kathryn FantauzziExecutive Officer, Director
- David RabinExecutive Officer, Director
- Sa'ad ShahDirector
- Offering amount
- $2M
- Amount sold
- $500K
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.3MraisedApr 2024 · 17 investors · Other Health CareRule 506(b)
▶$9.3MraisedApr 2024 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Sa'ad ShahDirector
- Alan CannistraroExecutive Officer, Director
- Kathryn FantauzziExecutive Officer, Director
- Gary JohnsonDirector
- David RabinExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $9.3M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8MraisedSep 2021 · 17 investors · Other Health CareRule 506(b)
▶$8MraisedSep 2021 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kathryn FantauzziExecutive Officer, Director, Promoter
- Offering amount
- $15M
- Amount sold
- $8M
- Sales commissions
- $84.8K
- Placement agents
- Melvin Pirchesky
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$5.9MraisedFeb 2021 · 51 investors · Other Health CareRule 506(b)
▶$5.9MraisedFeb 2021 · 51 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kathryn FantauzziExecutive Officer, Director, Promoter
- Offering amount
- $5.9M
- Amount sold
- $5.9M
- Sales commissions
- $80K
- Placement agents
- Boustead Securities, LLC
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$100KraisedMar 2018 · 1 investors · Other Health CareRule 506(b)
▶$100KraisedMar 2018 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kathryn FantauzziExecutive Officer, Director, Promoter
- Offering amount
- $250K
- Amount sold
- $100K
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Apollo Neuroscience do?
- Improves the body's resilience to stress to help users focus, sleep, and stay energized.
- Who founded Apollo Neuroscience?
- Apollo Neuroscience was founded by Kathryn Fantauzzi in 2017.
- Who are Apollo Neuroscience's investors?
- Apollo Neuroscience's investors include Noetic.
- How much funding has Apollo Neuroscience raised?
- Apollo Neuroscience has disclosed $23.8M raised across 5 rounds.
- Where is Apollo Neuroscience headquartered?
- Apollo Neuroscience is headquartered in Pittsburgh, US.